Challenges and considerations for development of therapeutic proteins in pediatric patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|S3|S103-S115

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.S3, 2015-03, pp. : S103-S115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The unique challenges of hemovigilance for pediatric patients

By  

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 466-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibacterial Drug Development: Challenges, Recent Developments, and Future Considerations

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 147-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 3, 2018-03 ,pp. : 419-433

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Drug Monitoring as a Component of Personalized Medicine: Applications in Pediatric Drug Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 138-140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of p53, EGFR, pRb and bcl-2 Proteins in Pediatric Glioblastoma Multiforme: A Study of 54 Patients

By  

Pediatric Neurosurgery, Vol. 41, Iss. 6, 2005-11 ,pp. : 292-299

Karger

Access to resources Recommend Favorite